CCChangguo Chen

Changguo Chen

*This is an algorithmically generated author record based on publicly available information.

Changguo Chen has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    6PPD-Quinone Binds Mitochondrial SUPV3L1 to Trigger Kupffer Cell Necroptosis and Metabolic Steatohepatitis

    by Ming Gao, Zijuan Qi, Longge Wang, Zeqing Sun, Qi Zhu, Chen Changguo, Changying Li, Youyou Dong

    N-(1,3-dimethylbutyl)-N’-phenyl-p-phenylenediamine quinone (6PPD-quinone, 6PPD-Q) is a tire-derived contaminant detected in human biospecimens. Although 6PPD-Q has been associated with hepatic toxicity, its effects at environmentally relevant low doses and the underlying molecular mechanisms remain unclear. Here, we show that elevated 6PPD-Q concentrations are associated with increased liver injury markers in humans. In mice, repeated low-dose exposure caused minimal overt hepatic injury but selectively induced ZBP1 activation in Kupffer cells. In macrophages, 6PPD-Q triggered RIPK3–MLKL signaling and ZBP1-dependent necroptosis, accompanied by increased mitochondrial Z-form nucleic acid accumulation. We identified the mitochondrial RNA helicase SUPV3L1 as a direct target of 6PPD-Q, whose dysfunction disrupted mitochondrial RNA homeostasis and promoted Z-form nucleic acid–mediated cell death. In mouse models of metabolic liver disease, low-dose 6PPD-Q exacerbated steatohepatitis, whereas inhibition of the ZBP1-RIPK3 pathway alleviated these effects. These findings reveal a previously unrecognized mechanism linking tire-derived pollution to mitochondrial RNA dysregulation and inflammatory cell death in the liver, and establish low-dose 6PPD-Q exposure as a disease-promoting factor that accelerates metabolic liver disease progression.

  • Open Access

    Perfluorooctane sulfonate directly interacts with IRF3 to attenuate antiviral innate immunity

    by Qiuju Liang, Yun Li, Zeqing Sun, Longge Wang, Changying Li, Peiyu Fang, Qi Zhang, Juan Li, Xiaoyi Sun, Changguo Chen, et al.

    Perfluorooctane sulfonate (PFOS), a prominent per- and polyfluoroalkyl substance (PFAS), has raised significant public health concerns due to its widespread use, environmental persistence, and bioaccumulation potential. Both epidemiological and experimental studies demonstrate that PFOS exposure causes immunotoxicity and disrupts both innate and adaptive immunity. However, the specific effects of PFOS on innate antiviral immunity remain poorly understood. Here, by integrating multi-omics analysis with in vitro and in vivo studies, we establish that PFOS exposure at subtoxic doses compromises antiviral defense by suppressing type I interferon production, thereby enhancing the replication of a broad range of viruses. Mechanistically, PFOS interacts with IRF3 at Val319, Asp328, and Arg341, inducing conformational changes that disrupt the TBK1–IRF3 interaction. This disruption inhibits subsequent IRF3 phosphorylation, dimerization, and nuclear translocation, which in turn suppresses type I interferon production and facilitates viral replication. Additionally, wild-type IRF3, but not a binding-deficient mutant, restores PFOS-mediated suppression of innate antiviral immunity in IRF3-deficient cells or knockout mice. Furthermore, association studies in patients with respiratory syncytial virus, influenza, or hepatitis B virus infection showed that elevated serum PFOS levels are correlated with increased viral loads, as indicated by lower Ct values or higher HBV DNA levels. Similarly, NHANES data link higher serum PFOS to lower vaccine antibody levels. Together, our results demonstrate that PFOS directly targets IRF3 to impair innate antiviral immunity, thereby enhancing host susceptibility to viral infection at environmental exposure levels.

  • Open Access

    Establishment and application of a rapid visualization method for detecting Vibrio parahaemolyticus nucleic acid

    by Yachao Hou, Xinping Liu, Ya'NAn Wang, Liang Guo, Lvying Wu, Wenrong Xia, Yongqi Zhao, Weiwei Xing, Jin Chen, Changguo Chen


  • Rapid visual nucleic acid detection of Vibrio alginolyticus by recombinase polymerase amplification combined with CRISPR/Cas13a

    by Yanan Wang, Yachao Hou, Xinping Liu, Na Lin, Youyou Dong, Fei Liu, Wenrong Xia, Yongqi Zhao, Weiwei Xing, Jin Chen, et al.

    Vibrio alginolyticus (V. alginolyticus) is a common pathogen in the ocean. In addition to causing serious economic losses in aquaculture, it can also infect humans. The rapid detection of nucleic acids of V. alginolyticus with high sensitivity and specificity in the field is very important for the diagnosis and treatment of infection caused by V. alginolyticus. Here, we established a simple, fast and effective molecular method for the identification of V. alginolyticus that does not rely on expensive instruments and professionals. The method integrates recombinase polymerase amplification (RPA) technology with CRISPR system in a single PCR tube. Using this method, the results can be visualized by lateral flow dipstick (LFD) in less than 50 min, we named this method RPA-CRISPR/Cas13a-LFD. The method was confirmed to achieve high specificity for the detection of V. alginolyticus with no cross-reactivity with similar Vibrio and common clinical pathogens. This diagnostic method shows high sensitivity; the detection limit of the RPA-CRISPR/Cas13a-LFD is 10 copies/µL. We successfully identified 35 V. alginolyticus strains from a total of 55 different bacterial isolates and confirmed their identity by (Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, MALDI-TOF MS). We also applied this method on infected mice blood, and the results were both easily and rapidly obtained. In conclusion, RPA-CRISPR/Cas13a-LFD offers great potential as a useful tool for reliable and rapid diagnosis of V. alginolyticus infection, especially in limited conditions. Graphical abstract


  • Open Access

    Rapid visual nucleic acid detection of Vibrio alginolyticus by RPA combined with CRISPR/Cas13a

    by Yanan Wang, Yachao Hou, Xinping Liu, Na Lin, Youyou Dong, Fei Liu, Wenrong Xia, Yongqi Zhao, Weiwei Xing, Jin Chen, et al.

    Vibrio alginolyticus (V. alginolyticus) is a common pathogen that infects humans and animals. In addition to causing serious economic losses in aquaculture, it can also infect humans. The rapid detection of nucleic acids of V. alginolyticus with high sensitivity and specificity in the field is very important for the diagnosis and treatment of infection caused by V. alginolyticus. Here, we established a simple, fast and effective molecular method for the identification of V. alginolyticus that does not rely on expensive instruments and professionals. The method integrates RPA technology with CRISPR technology in a single PCR tube. Using this method, the results can be visualized by lateral flow dipstick in less than 50 minutes. The method was confirmed to achieve high specificity for the detection of V. alginolyticus with no cross-reactivity with similar Vibrio and common clinical pathogens. This diagnostic method shows high sensitivity; the detection limit of the RPA-CRISPR/Cas13a-LFD is 10 copies µL-1. The results for 55 wild strains were consistent with TaqMan-qPCR, and it can be concluded that the methods have 100% sensitivity and 100% specificity. In conclusion, RPA-CRISPR/Cas13a offers great potential as a useful tool for reliable and rapid diagnosis of V. alginolyticus infection, especially in limited conditions.

  • Open Access

    Rapid visual nucleic acid detection of Vibrio alginolyticus by RPA combined with CRISPR/Cas13a

    by Yanan Wang, Yachao Hou, Xinping Liu, Na Lin, Youyou Dong, Fei Liu, Wenrong Xia, Yongqi Zhao, Weiwei Xing, Jin Chen, et al.

    Vibrio alginolyticus ( V. alginolyticus) is a common pathogen that infects humans and animals. In addition to causing serious economic losses in aquaculture, it can also infect humans. The rapid detection of nucleic acids of V. alginolyticus with high sensitivity and specificity in the field is very important for the diagnosis and treatment of infection caused by V. alginolyticus. Here, we established a simple, fast and effective molecular method for the identification of V. alginolyticus that does not rely on expensive instruments and professionals. The method integrates RPA technology with CRISPR technology in a single PCR tube. Using this method, the results can be visualized by lateral flow dipstick in less than 50 minutes. The method was confirmed to achieve high specificity for the detection of V. alginolyticus with no cross-reactivity with similar Vibrio and common clinical pathogens. This diagnostic method shows high sensitivity; the detection limit of the RPA-CRISPR/Cas13a-LFD is 10 copies μL -1. The results for 55 wild strains were consistent with TaqMan-qPCR, and it can be concluded that the methods have 100% sensitivity and 100% specificity. In conclusion, RPA-CRISPR/Cas13a offers great potential as a useful tool for reliable and rapid diagnosis of V. alginolyticus infection, especially in limited conditions.

  • Dual Roles of Tumor Necrosis Factor Superfamily 14 in Antiviral Immunity

    by Yachao Hou, Yanan Wang, Jin Chen, Changguo Chen

    Tumor necrosis factor superfamily 14 (TNFSF14) (LIGHT) is an interesting costimulatory molecule associated with T lymphocyte activation, and it mainly exerts its biological effects by binding to its receptors herpesvirus invasion mediator (HVEM) and lymphotoxin-β receptor. Research shows that TNFSF14 plays a critical regulatory role in immune responses to viral infection, but its role is different in different diseases. TNFSF14 can be a cytokine neutralization target during novel coronavirus infection, and anti-TNFSF14 monoclonal antibody treatment can reduce the risk of respiratory failure and mortality. When the host is infected with adenovirus, TNFSF14 can be used as an inflammatory biomarker to indicate whether there was an adenovirus infection in the host and the degree of disease caused by viral infection. When hosts suffer influenza virus infection, the TNFSF14-HVEM signaling pathway can stimulate the maturation and proliferation of memory CD8+ T cells, which helps the host immune system stimulate a second immune response against respiratory virus infection. TNFSF14 can act as an immune adjuvant and enhance the immunogenicity of the human papillomavirus (HPV) DNA vaccine when the host is infected with HPV. During hepatitis virus infection, TNFSF14 acts as a proinflammatory factor, participates in inflammation and causes tissue damage. In conclusion, TNFSF14 plays different and significant roles in diverse viral infections. This article reviews the current research on TNFSF14 in antiviral immunity.


    • 1 September 2020
      • Vol. 50  (5) , 650-656

    The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer

    by Changguo Chen, Qiuyuan Chen, Youyou Dong, Xinping Liu

    Objective. Breast cancer is a common type of malignant tumour worldwide and the second leading cause of death in women. The present study aims to investigate the clinical significance of serum soluble intercellular adhesion molecule-1 (sICAM-1) in differentiating benign breast lesions from breast cancer. Methods. Plasma samples were obtained from 200 breast cancer patients, 47 patients with benign breast lesions and 50 age- and sex-matched healthy individuals as controls. Plasma levels of sICAM-1 were measured in all the samples using commercially available enzyme-linked immune-sorbent assay (ELISA) kits. The serum levels of carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) were detected by the UniCel (R) Dxl 800 Immunoassay System with matched kits. Results. The plasma levels of CEA and CA15-3 were 1.22 +/- 0.2 (ng/mL) and 6.39 +/- 1.5 (ng/mL) in the healthy control group, 1.40 +/- 0.3 (ng/mL) and 5.81 +/- 2.1 (ng/mL) in the benign breast lesion (BBL) group, and 5.29 +/- 0.6 (ng/mL) and 27.08 +/- 5.7 (ng/mL) in the breast cancer (BC) group. Plasma levels of CEA and CA15-3 in the BC group were significantly higher than those in the BBL and healthy control groups (all P<0.05), but the plasma levels of CEA and CA15-3 were not significantly different between the BBL group and the healthy control group, P=0.548 and P=0.2976, respectively. The diagnostic sensitivity and specificity were 13.4% and 98.0% for CEA and 22.2% and 100.0% for CA15-3. For plasma sICAM-1, the diagnostic sensitivity and specificity were 98% and 94% at a cut-off value of 20.0 (ng/mL), with an area under the receiver operating characteristic (ROC) curve of 0.99, which could be used to distinguish between healthy controls and the BC group; the diagnostic sensitivity and specificity were 95.5% and 94.0% at a cut-off value of 20.0 (ng/mL) with an area under the ROC curve of 0.98, which could be used to distinguish between healthy controls and the BBL group; and the diagnostic sensitivity and specificity were 44.6% and 94.1% at a cut-off value of 40.0 (ng/mL), with an area under ROC curve of 0.68, which could be used to distinguish between the BBL group and the BC group. The plasma levels of sICAM-1 were 15.43 +/- 2.3 (ng/mL) in healthy controls, 29.8 +/- 3.5 (ng/mL) in the BBL group, and 50.07 +/- 12.2 (ng/mL) in the BC group. The plasma level of sICAM-1 in the BC group was the highest among all three groups (all P<0.05). Conclusions. The CEA, CA15-3 and sICAM-i levels were increased in breast cancer patients, especially in those with node and/or organ metastasis. After diagnosis, CEA, CA15-3 and sICAM-1 levels are closely related to tumour metastasis. sICAM-1 has great potential value in the clinical diagnosis of benign breast lesions and breast cancer.


    • 1 May 2019
      • Vol. 49  (3) , 302-308

    Clinical Significance of let-7a-5p and miR-21-5p in Patients with Breast Cancer

    by Changguo Chen, Xinping Liu, Changwei Chen, Qiuyuan Chen, Youyou Dong, Bingbing Hou

    Objective. To investigate the clinical significance of serum let-7a-5p and miR-21-5p in the diagnosis of breast cancer. Methods. We examined 32 healthy people and 30 patients with benign breast lesions as controls and 90 breast cancer patients as study subjects. The expression of let-7a-5p and miR-21-5p were detected in all subjects' samples, and Cel-miR-39-3p was used as a spike-in reference. Serum miRNAs were extracted by the TRIzol method, and reverse transcription was performed with specific primers for let-7a-5p, miR-21-5p and Cel-miR-39-3p, and 2-mu L reverse transcription products were used as PCR templates. A SLAN-96P fluorescent quantitative PCR instrument was used for quantitative PCR detection. Results. (1) The serum levels of carcinoembryonic antigen (CEA)and carbohydrate antigen 15-3 (CA15-3) in the breast cancer group were higher than those in the healthy controls and patients with benign breast lesions; (2) The expression level of let-7a-5p in the serum of the breast cancer group was lower than that in the healthy control group (P0.05); (3) The serum expression level of miR-21-5p in the breast cancer group was lower than that in the healthy control group (P0.05). Conclusion. Reduced expression of Let-7a-5p and miR-21-5p levels is of little value for early diagnosis of breast cancer; however reduced expression of Let-7a-5p and miRNA-21-5p may serve as non-invasive biomarkers for the diagnosis of breast cancer metastasis, and combination of these markers with CEA and CA15-3 can help to distinguish benign breast lesions from breast cancer.


  • Open Access

    The Distribution Frequency of Interferon-Gamma Receptor 1 Gene Polymorphisms in Interferon-γRelease Assay-Positive Patients

    by Changguo Chen, Lei Chen, Changwei Chen, Qiuyuan Chen, Qiangyuan Zhao, Youyou Dong

    Tuberculosis is caused by mycobacterium, a potentially fatal infectious bacterium. In recent years, TB cases increased in the whole world. WHO statistics data shows that the world’s annual tuberculosis incidence was 8~10 million with about 3 million deaths. Several studies have shown that susceptibility to tuberculosis may be associated with IFNGR1 gene polymorphisms. Here, we report the distribution frequency of IFNGR1 gene polymorphisms in 103 cases of IGA-negative patients and 100 cases of IGA-positive patients from China by sequencing the IFNGR1 proximal ~750 bp promoter region. We found a total of 5 types of site mutations: -611 (G/A), -56 (T/C), -255 (C/T), -359 (T/C), and -72 (C/T). The two main types of gene polymorphisms among the IGA-negative and IGA-positive groups were -611 (G/A), with mutation rates of 88.3% and 78.4%, respectively, and -56 (T/C), with mutation rates of 84.5% and 83.8%, respectively, which had no statistical significance, and there was no correlation with the incidence of tuberculosis.